Ascendis Pharma A/S Sustainability Reports

Ascendis Pharma A/S is a biopharmaceutical company that develops prodrug therapies using its proprietary TransCon technology. Its pipeline focuses on addressing clinical unmet needs within endocrinology rare diseases and oncology.

Sector: Manufacturing

Country: Denmark

Exchange: Nasdaq

LEI: 549300B66JN3W3J8GH73

16 reports from 2016 to 2025

• Ascendis Pharma A/S 2025 Annual Report
• Ascendis Pharma A/S 2025 Corporate Responsibility & P ESG Report
• Ascendis Pharma A/S 2024 Annual Report
• Ascendis Pharma A/S 2024 Sustainability & P ESG Report
• Ascendis Pharma A/S 2023 Annual Report